NCT06190717 Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
| NCT ID | NCT06190717 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sonavex, Inc. |
| Condition | Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 304 participants |
| Start Date | 2024-02-21 |
| Primary Completion | 2027-02-01 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This is a prospective, multi-center, two-arm, randomized trial to quantify the performance of the EchoMark®/EchoSure® System for AVF diagnostic ultrasound when used under a protocol of biweekly use for assessing fistula maturation and reducing time to Clinical Maturation.
Eligibility Criteria
Inclusion Criteria: * Males or non-pregnant, non-breastfeeding females ≥ 18 years of age but \< 85 years of age at the time of informed consent. * Subject is able and willing to provide written informed consent prior to receiving any non-standard of care, protocol specific procedures. * Subject is willing and capable of complying with all required follow-up visits. * Subject and/or Care Team agree that the distance and transportation resources from the patient's home to the clinic are reasonable for study participation and compliance. * Subject has an estimated life expectancy \> 18 months. * Subject is ambulatory (cane or walker are acceptable). * CKD Stage 5 (eGFR less than 10) or ESRD subjects presenting for upper arm autologous arteriovenous fistula creation that is not transposed for hemodialysis access. * Subjects who are currently on dialysis through a CVC or who imminently require dialysis (GFR \<10). * Vein diameter ≥ 2.5 mm at the antecubital fossa per vein mapping. * Artery
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.